Search Results - "Schizophrenia"

Effect of atypical antipsychotic on blood pressure in inpatients with schizophrenia of Prof. Dr. Soerojo Mental Health Hospital Magelang by Haafizah Dania, Melisa I Barliana, Dyah A Perwitasari, Rizky Abdulah

Connect to this object online.

Use of atypical antipsychotics in the treatment of schizophrenia in the Brazilian National Health System: a cohort study, 2008-2017 by Izabela Fulone, Marcus Tolentino Silva, Luciane Cruz Lopes

Connect to this object online.

Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients by Jing Huang, Jing Huang, Jing Huang, Gang-Rui Hei, Gang-Rui Hei, Gang-Rui Hei, Ye Yang, Ye Yang, Ye Yang, Chen-Chen Liu, Chen-Chen Liu, Chen-Chen Liu, Jing-Mei Xiao, Jing-Mei Xiao, Jing-Mei Xiao, Yu-Jun Long, Yu-Jun Long, Yu-Jun Long, Xing-Jie Peng, Xing-Jie Peng, Xing-Jie Peng, Yi Yang, Jing-Ping Zhao, Jing-Ping Zhao, Jing-Ping Zhao, Ren-Rong Wu, Ren-Rong Wu, Ren-Rong Wu, Ren-Rong Wu

Connect to this object online.

Editorial: Decreasing the Impact of Treatment Resistance in Schizophrenia: Identifying Novel Molecular Targets/Pathways to Increase Treatment Efficacy by Mirko Manchia, Mirko Manchia, Mirko Manchia, Bernardo Carpiniello, Bernardo Carpiniello

Connect to this object online.

THE EFFECT OF FAMILY THERAPY WITH SPIRITUAL APPROACH TOWARD FAMILY'S HEALTH BELIEF MODEL IN TAKING CARE OF PATIENT WITH SCHIZOPHRENIA by Ah. Yusuf

Connect to this object online.

The impact of territorial care in the treatment of people diagnosed with schizophrenia and delusional disorders in a Rio de Janeiro community by Joana Thiesen, Sandra Fortes, Maria Tavares Cavalcanti

Connect to this object online.

Clinical and Diagnostic Value of High-Density Lipoprotein-Based Inflammatory Indices and Lipid Ratios in Young Adults with Schizophrenia by Chen L, Zheng C, Luan H, Chen X

Connect to this object online.

Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia by Michele Wilson, Benjamin Gutierrez, Steve J Offord, Christopher M Blanchette, Anna Eramo, Stephanie Earnshaw, Siddhesh A Kamat

Connect to this object online.

The effects of high-frequency repetitive transcranial magnetic stimulation on auditory hallucinations and working memory among patients with schizophrenia by Najmeh Hamid, Shekofe Rezaeemanesh, Reza Rostami

Connect to this object online.

Association Study of Tumor Necrosis Factor Receptor 1 (TNFR1) Gene Polymorphisms with Schizophrenia in the Polish Population by Renata Suchanek-Raif, Krzysztof Kucia, Małgorzata Kowalczyk, Paweł Raif, Monika Paul-Samojedny, Anna Fila-Daniłow, Jan Kowalski

Connect to this object online.

Reelin Alterations, Behavioral Phenotypes, and Brain Anomalies in Schizophrenia: A Systematic Review of Insights From Rodent Models by Ana C. Sánchez-Hidalgo, Ana C. Sánchez-Hidalgo, Celia Martín-Cuevas, Celia Martín-Cuevas, Benedicto Crespo-Facorro, Benedicto Crespo-Facorro, Benedicto Crespo-Facorro, Nathalia Garrido-Torres, Nathalia Garrido-Torres, Nathalia Garrido-Torres

Connect to this object online.

Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil by Izabela Fulone, Marcus Tolentino Silva, Luciane Cruz Lopes

Connect to this object online.

A Repeated Time-to-Positive Symptoms Improvement among Malaysian Patients with Schizophrenia Spectrum Disorders Treated with Clozapine by Orwa Albitar, Sabariah Noor Harun, Siti Nor Aizah Ahmad, Siti Maisharah Sheikh Ghadzi

Connect to this object online.

Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade by Sebastiano Alfio Torrisi, Salvatore Salomone, Federica Geraci, Filippo Caraci, Filippo Caraci, Claudio Bucolo, Filippo Drago, Gian Marco Leggio

Connect to this object online.

Antipsychotic Potential of Quinazoline ErbB1 Inhibitors in a Schizophrenia Model Established With Neonatal Hippocampal Lesioning by Makoto Mizuno, Yuriko Iwakura, Masako Shibuya, Yingjun Zheng, Takeyoshi Eda, Taisuke Kato, Yohei Takasu, Hiroyuki Nawa

Connect to this object online.

Risk of schizophrenia in patients with polycystic ovary syndrome: a nationwide population-based cohort study from Taiwan by Shih-Fen Chen, Yu-Cih Yang, Chung-Y Hsu, Yu-Chih Shen

Connect to this object online.

Age of Onset Moderates the Association between Total Antioxidant Capacity and Cognitive Deficits in Patients with Drug-Naïve Schizophrenia by Jiaxin Li, Deyang Li, Junru Guo, Dongmei Wang, Xiangyang Zhang

Connect to this object online.

Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial by F. Markus Leweke, F. Markus Leweke, F. Markus Leweke, Cathrin Rohleder, Cathrin Rohleder, Christoph W. Gerth, Christoph W. Gerth, Martin Hellmich, Ralf Pukrop, Dagmar Koethe, Dagmar Koethe

Connect to this object online.

A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss by Möller Hans-Jürgen, Heeg Bart, Treur Maarten, Schmeding Annette, van Hout Ben

Connect to this object online.

The use of the Health of the Nation Outcome Scales for assessing functional change in treatment outcome monitoring of patients with chronic schizophrenia by Stephan T. Egger, Stefan Vetter, Godehard Weniger, Caroline Vandeleur, Erich Seifritz, Mario Müller

Connect to this object online.